Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu


Welcome to the Multiple Sclerosis Discovery Forum

An online community and information portal that aims to inspire connections and clinical advances



Become a Member

News & Future Directions

New Findings | 29 Jan 2015

More Encouraging Results From Stem-Cell Transplants

A new study shows good outcomes using a less intense conditioning regimen, suggesting it may be possible to perform successful stem-cell transplants in multiple sclerosis patients with less risk of infection

According to some, 2015 is the year of the future. And that tongue-in-cheek superlative (derived from...
News Briefs | 20 Jan 2015

Glatiramer Acetate and the Interferon Betas Are Clinically Similar

Following on the heels of a Cochrane meta-analysis earlier in 2014, a new study finds that MS patients followed over 10 years have similar annualized relapse rates whether they take glatiramer acetate or one of the interferon betas

No matter how you slice it, glatiramer acetate and the interferon betas appear to be...
News Briefs | 16 Jan 2015

Corpus Callosum Cross-Section Correlated With Cognitive Decline

A new longitudinal study of people with MS found that the cross-sectional area of the midsagittal corpus callosum was highly associated with cognitive decline and moderately associated with physical disability over a 17-year period

A 17-year longitudinal study published online ahead of print in the Multiple Sclerosis Journal found that...

Research Resources

Tools that will help investigators conceive and perform experimental work:

  • The Data Visualization section presents MS-related data in new ways, making it easy for viewers to discover unexpected relationships
    Our latest visualization details the design of 88 clinical trials with magnetic resonance imaging reports published between 1993 and 2014. It makes it easy to see which of five key measurements were reported in each trial and when during the course of that trial those measurements were made.

  • Drug-Development Pipeline consolidates key information about compounds under investigation for therapeutic use
    We've recently added two new trials and eight other pieces of information. The drugs with important additions are dalfampridine, fingolimod, interferon β-1b, and natalizumab.
  • Tissue Repositories lists features of the world's tissue repositories and brain banks, including rules of engagement and contact information
  • MSGene provides a comprehensive, unbiased and regularly updated collection of genetic association studies performed on multiple sclerosis phenotypes
  • Animal Models summarizes the promises and pitfalls of animal models used in MS research
    We've added a detailed review of zebrafish as a model organism in MS research.

  • Clinical Trials lists sources of information about MS clinical trials

Professional Resources


Recent Comments

News Briefs | 21 Jan 2015
The results of this study and that of a previous...
News Briefs | 16 Jan 2015
This study shows the robustness of corpus...
New Findings | 14 Jan 2015
I think NEDA is laudable but the results are...

MSDF Tweets

NYAS T Cell Meeting

In the News
Read Science Translational Medicine's article about MS Discovery Forum